- Report
- March 2024
- 123 Pages
North America
From €1342EUR$1,500USD£1,180GBP
- Report
- March 2024
- 140 Pages
Middle East, Africa
From €1342EUR$1,500USD£1,180GBP
- Report
- March 2024
- 358 Pages
Global
From €3221EUR$3,600USD£2,832GBP
- Training
- October 2026
- 1 Day
Global
€587EUR$680USD£499GBP
€705EUR$816USD£599GBP
- Newsletter
- November 2025
- 4 Pages
Global
From €179EUR$200USD£157GBP
- Report
- May 2025
- 80 Pages
From €2639EUR$2,950USD£2,320GBP
- Report
- April 2025
- 80 Pages
Vietnam
From €4339EUR$4,850USD£3,815GBP
- Report
- November 2024
- 750 Pages
Global
From €1789EUR$2,000USD£1,573GBP
- Report
- October 2024
- 70 Pages
North America
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
Latin America
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
China
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
France
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
Germany
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
India
From €850EUR$950USD£747GBP
- Report
- October 2024
- 70 Pages
United States
From €850EUR$950USD£747GBP
- Report
- September 2024
- 103 Pages
United States
From €2232EUR$2,495USD£1,962GBP
- Report
- September 2024
- 97 Pages
Global
From €4339EUR$4,850USD£3,815GBP
- Report
- July 2024
- 639 Pages
Global
From €3802EUR$4,250USD£3,343GBP
- Report
- July 2024
- 90 Pages
China
From €1610EUR$1,800USD£1,416GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more